Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Few population-based studies have investigated the association between melanoma and autoimmune diseases in Asian populations. We conducted a population-based cross-sectional study using the South Korean National Health Insurance database to investigate the association between melanoma and autoimmune diseases in Asian individuals. Melanoma patients were identified, and birth year and sex matched controls were randomly selected at a 1:10 ratio. Multivariable logistic regression was used to evaluate the association between melanoma and autoimmune diseases. The study involved 12 040 melanoma patients and 120 400 matched controls. Melanoma patients had significantly higher odds of vitiligo (adjusted odds ratio [aOR], 4.05; 95% confidence interval [CI], 3.38-4.85), ulcerative colitis (aOR, 1.81; 95% CI, 1.24-2.62), psoriasis (aOR, 1.54; 95% CI, 1.32-1.79), Hashimoto's thyroiditis (aOR, 1.50; 95% CI, 1.21-1.85), ankylosing spondylitis (aOR, 1.42; 95% CI, 1.06-1.91), and type 1 diabetes mellitus (aOR, 1.27; 95% CI, 1.08-1.49). Most autoimmune diseases showed a stronger association with melanoma in younger individuals (aged 20-60 years) compared to older individuals (aged > 60 years). In conclusion, melanoma was significantly associated with several autoimmune diseases, suggesting shared pathophysiological mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.17945DOI Listing

Publication Analysis

Top Keywords

autoimmune diseases
24
association melanoma
20
melanoma autoimmune
16
melanoma patients
12
melanoma
8
diseases asian
8
matched controls
8
individuals aged
8
autoimmune
6
diseases
6

Similar Publications

Importance: Janus kinase (JAK) inhibitors are highly effective medications for several immune-mediated inflammatory diseases (IMIDs). However, safety concerns have led to regulatory restrictions.

Objective: To compare the risk of adverse events with JAK inhibitors vs tumor necrosis factor (TNF) antagonists in patients with IMIDs in head-to-head comparative effectiveness studies.

View Article and Find Full Text PDF

Lysosome-dependent cell death (LDCD) is a regulated form of cell death initiated by increased lysosomal membrane permeability, leading to the cytoplasmic release of lysosomal enzymes and subsequent cellular damage. Molecular mechanisms controlling LDCD include lysosomal membrane instability and lysosomal enzyme release, which together lead to cell damage. A more profound comprehension of these underlying mechanisms may reveal new therapeutic targets for diseases associated with lysosomal dysfunction.

View Article and Find Full Text PDF

Human cytomegalovirus (HCMV) infects up to 80% of the world's population. Here, we show that HCMV infection leads to widespread changes in human chromatin accessibility and chromatin looping, with hundreds of thousands of genomic regions affected 48 hr after infection. Integrative analyses reveal HCMV-induced perturbation of Hippo signaling through drastic reduction of TEAD1 transcription factor activity.

View Article and Find Full Text PDF

AppRaise: Software for Quantifying Evidence Uncertainty in Systematic Reviews Using a Posterior Mixture Model.

J Eval Clin Pract

September 2025

Health Technology Assessment Unit, Acute and Hospital-Based Care Portfolio, Ontario Health, Toronto, Ontario, Canada.

Rationale: Systematic reviews are essential for evidence-based healthcare decision-making. While it is relatively straightforward to quantitatively assess random errors in systematic reviews, as these are typically reported in primary studies, the assessment of biases often remains narrative. Primary studies seldom provide quantitative estimates of biases and their uncertainties, resulting in systematic reviews rarely including such measurements.

View Article and Find Full Text PDF